Literature DB >> 1658834

Mutational analysis of att554, the target of the site-specific transposon Tn554.

E Murphy1, E Reinheimer, L Huwyler.   

Abstract

Tn554 is a high-frequency, site-specific transposable element of Staphylococcus aureus which has integrative properties resembling those of temperate bacteriophages. Tn554 inserts at a unique chromosomal location, designated att554. att554 contains a core hexanucleotide sequence, 5'-GATGTA-3' (nucleotides numbered -3 to +3). Most of the time (greater than 99%) insertion occurs immediately 3' to this sequence; the resulting orientation of Tn554 to att554 is designated as the (+) orientation. Infrequent insertions immediately 5' to the core sequence result in the opposite, or (-) orientation. Mutational analysis of a cloned att554 site indicates that deletions extending from the left and ending at -15 or from the right ending between +8 and +12 reduced attachment site efficiency. Plasmids with deletions extending closer to the insertion site, although still retaining the core sequence from -3 to +3, were totally inactive. Tn554 insertions into partially active att554 sites retained normal site- and orientation-specificity with respect to att554, but they frequently contained abnormal sequences at the junction of att554 and the 3' end of Tn554. These data indicate that att554 contains a short nucleotide sequence essential for transposition and flanking sequences that greatly increase the frequency of recombination.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1658834     DOI: 10.1016/0147-619x(91)90033-s

Source DB:  PubMed          Journal:  Plasmid        ISSN: 0147-619X            Impact factor:   3.466


  9 in total

1.  Tn6674 Is a Novel Enterococcal optrA-Carrying Multiresistance Transposon of the Tn554 Family.

Authors:  Dexi Li; Xing-Yun Li; Stefan Schwarz; Mengyan Yang; Su-Mei Zhang; Wenbo Hao; Xiang-Dang Du
Journal:  Antimicrob Agents Chemother       Date:  2019-08-23       Impact factor: 5.191

2.  IS21-558 insertion sequences are involved in the mobility of the multiresistance gene cfr.

Authors:  Corinna Kehrenberg; Frank M Aarestrup; Stefan Schwarz
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

3.  Florfenicol-chloramphenicol exporter gene fexA is part of the novel transposon Tn558.

Authors:  Corinna Kehrenberg; Stefan Schwarz
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

4.  Tn5406, a new staphylococcal transposon conferring resistance to streptogramin a and related compounds including dalfopristin.

Authors:  Julien Haroche; Jeanine Allignet; Névine El Solh
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

5.  Prevalence of erm gene classes in erythromycin-resistant Staphylococcus aureus strains isolated between 1959 and 1988.

Authors:  H Westh; D M Hougaard; J Vuust; V T Rosdahl
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

6.  The glycyl radical enzyme TdcE can replace pyruvate formate-lyase in glucose fermentation.

Authors:  G Sawers; C Hesslinger; N Muller; M Kaiser
Journal:  J Bacteriol       Date:  1998-07       Impact factor: 3.490

7.  Towards a more accurate annotation of tyrosine-based site-specific recombinases in bacterial genomes.

Authors:  Rob Van Houdt; Raphael Leplae; Gipsi Lima-Mendez; Max Mergeay; Ariane Toussaint
Journal:  Mob DNA       Date:  2012-04-13

8.  TnCentral: a Prokaryotic Transposable Element Database and Web Portal for Transposon Analysis.

Authors:  Karen Ross; Alessandro M Varani; Erik Snesrud; Hongzhan Huang; Danillo Oliveira Alvarenga; Jian Zhang; Cathy Wu; Patrick McGann; Mick Chandler
Journal:  mBio       Date:  2021-09-14       Impact factor: 7.867

9.  Comparative genomics of global optrA-carrying Enterococcus faecalis uncovers a common chromosomal hotspot for optrA acquisition within a diversity of core and accessory genomes.

Authors:  Ana R Freitas; Ana P Tedim; Carla Novais; Val F Lanza; Luísa Peixe
Journal:  Microb Genom       Date:  2020-03-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.